Surmodics: Surmodics' SurVeil DCB Matches IN.PACT Admiral In Efficacy With Lower Drug Dose In Global Trial
(RTTNews) - Surmodics, Inc. (SRDX) has published results from the TRANSCEND trial, a pivotal global study demonstrating that its SurVeil drug-coated balloon (DCB) is non-inferior in safety and efficacy to the market-leading IN.PACT Admiral DCB-despite using a 75% lower drug dose.
Read full article »
SurModics is a Minnesota-based medical device firm that manufactures and supplies products such as in-vitro diagnostic kits and hydrophilic coatings for the healthcare sector.
Read more